Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Buphenyl Therapy for Byler's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01784718
Expanded Access Status : No longer available
First Posted : February 6, 2013
Last Update Posted : February 6, 2013
Information provided by (Responsible Party):
University of Pittsburgh

Brief Summary:
This is a single patient compassionate use protocol to determine whether Buphenyl (4-phenylbutyrate) will improve the poor bile flow associated with Byler Disease.

Condition or disease Intervention/treatment
Byler Disease Drug: Buphenyl

Layout table for study information
Study Type : Expanded Access
Official Title: Compassionate Use of Buphenyl® in the Treatment of Byler's Disease

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   1 Year and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All

Inclusion Criteria:

  • Byler Disease
  • Cholestasis unresponsive to pharmacologic therapy

Exclusion Criteria:

  • Allergy/Hypersensitivity to Buphenyl

No Contacts or Locations Provided

Layout table for additonal information
Responsible Party: University of Pittsburgh Identifier: NCT01784718    
Other Study ID Numbers: PRO12070385
First Posted: February 6, 2013    Key Record Dates
Last Update Posted: February 6, 2013
Last Verified: February 2013
Additional relevant MeSH terms:
Layout table for MeSH terms
Cholestasis, Intrahepatic
Bile Duct Diseases
Biliary Tract Diseases
Digestive System Diseases
Liver Diseases
4-phenylbutyric acid
Antineoplastic Agents